Iran National Cancer Control Program

National Cancer Control Program in Iran is prepared using recommendations of WHO and IAEA and in the framework of the PACT mission. This program (with 4 main and 7 supporting components) is being implemented and determines the policies, strategies, goals and activities for cancer control from 2013 to 2025.For cancer prevention, in addition to programs for controlling NCD-related risk factors in the level of society and PHC, producing HPV vaccine and implementing the vaccination program from 2020 is on the way.For cancer early detection, Iran has a national protocol for 3 cancers (Breast, Cervix and colorectal) and after a pilot phase in 2016 and 2017, it is expanding in selected population of each province by delivering basic PHC services along with a referral system to 137 cancer early detection centers designed and prepared for this purpose. One of the achievements of this program was the establishment of a national comprehensive laboratory in the form of Public Private Partnership (PPP) and providing the opportunity to perform HPV testing at low cost and high quality with insurance coverage as well as producing the FIT test in the country.For cancer diagnosis and treatment, preparing and implementing National clinical practice guidelines for 12 costly cancer drugs has led to standardization of services and more than 10% saving in costs. We also have guidelines for Breast, colon, gastric, lung and prostate cancer. In this context, implementing the national cancer spatial Program and preparing the document for National Cancer Care Network Development , has set Iran s roadmap in the next 10 years for developing infrastructure and equipment, as well as the human resources required.For palliative care, holding educational programs for general practitioners and nurses can provide the means to give outpatient and home care services from year 2020.Over the past 6 years, the National Population Based Cancer Registry in Iran has improved greatly in terms of qualitative and quantitative indicators, including coverage, quality, and timeliness, by modifying the processes and conducting numerous workshops. Our annual report has been the basis for GLOBOCAN. We will be able to receive pathology data online, record information about cancer care and stage of the disease in year 2020, Using the integrated cancer information management system.Given the comprehensiveness of the National Cancer Control Program, Iran can share its experiences with other countries.